vs
LEXICON PHARMACEUTICALS, INC.(LXRX)与High Roller Technologies, Inc.(ROLR)财务数据对比。点击上方公司名可切换其他公司
High Roller Technologies, Inc.的季度营收约是LEXICON PHARMACEUTICALS, INC.的1.1倍($6.3M vs $5.5M),High Roller Technologies, Inc.净利率更高(58.4% vs -282.7%,领先341.1%),LEXICON PHARMACEUTICALS, INC.同比增速更快(254.4% vs -16.4%)
Lexicon制药是一家成立于1995年的生物制药企业,总部位于美国得克萨斯州伍德兰兹,最初名为Lexicon Genetics,专注于开发人类疾病治疗药物。公司凭借专利小鼠基因敲除技术与强大的体内筛选能力,在Genome5000项目中完成了近5000个基因的研究,筛选出大量候选药物靶点。
该企业主营游乐设施业务,凭借气动驱动技术打造各类游乐设备,专业从事过山车设计研发,在游乐设施设计制造领域拥有相关技术积累与行业经验。
LXRX vs ROLR — 直观对比
营收规模更大
ROLR
是对方的1.1倍
$5.5M
营收增速更快
LXRX
高出270.8%
-16.4%
净利率更高
ROLR
高出341.1%
-282.7%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $5.5M | $6.3M |
| 净利润 | $-15.5M | $3.7M |
| 毛利率 | 96.3% | — |
| 营业利润率 | -269.1% | 1.3% |
| 净利率 | -282.7% | 58.4% |
| 营收同比 | 254.4% | -16.4% |
| 净利润同比 | 54.0% | 831.9% |
| 每股收益(稀释后) | $-0.04 | $0.39 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
LXRX
ROLR
| Q4 25 | $5.5M | — | ||
| Q3 25 | $14.2M | $6.3M | ||
| Q2 25 | $28.9M | $6.9M | ||
| Q1 25 | $1.3M | $6.8M | ||
| Q4 24 | $1.6M | — | ||
| Q3 24 | $1.7M | $7.5M | ||
| Q2 24 | $1.6M | — | ||
| Q1 24 | $1.1M | — |
净利润
LXRX
ROLR
| Q4 25 | $-15.5M | — | ||
| Q3 25 | $-12.8M | $3.7M | ||
| Q2 25 | $3.3M | $-592.0K | ||
| Q1 25 | $-25.3M | $-3.3M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-64.8M | $-501.0K | ||
| Q2 24 | $-53.4M | — | ||
| Q1 24 | $-48.4M | — |
毛利率
LXRX
ROLR
| Q4 25 | 96.3% | — | ||
| Q3 25 | 99.9% | — | ||
| Q2 25 | 99.9% | — | ||
| Q1 25 | 97.6% | — | ||
| Q4 24 | 77.5% | — | ||
| Q3 24 | 95.9% | — | ||
| Q2 24 | 89.7% | — | ||
| Q1 24 | 97.2% | — |
营业利润率
LXRX
ROLR
| Q4 25 | -269.1% | — | ||
| Q3 25 | -85.9% | 1.3% | ||
| Q2 25 | 12.9% | -7.2% | ||
| Q1 25 | -2034.8% | -47.4% | ||
| Q4 24 | — | — | ||
| Q3 24 | -3658.4% | -6.3% | ||
| Q2 24 | -3423.3% | — | ||
| Q1 24 | -4147.6% | — |
净利率
LXRX
ROLR
| Q4 25 | -282.7% | — | ||
| Q3 25 | -90.0% | 58.4% | ||
| Q2 25 | 11.3% | -8.5% | ||
| Q1 25 | -2004.4% | -48.4% | ||
| Q4 24 | — | — | ||
| Q3 24 | -3722.6% | -6.7% | ||
| Q2 24 | -3304.2% | — | ||
| Q1 24 | -4427.9% | — |
每股收益(稀释后)
LXRX
ROLR
| Q4 25 | $-0.04 | — | ||
| Q3 25 | $-0.04 | $0.39 | ||
| Q2 25 | $0.01 | $-0.07 | ||
| Q1 25 | $-0.07 | $-0.39 | ||
| Q4 24 | — | — | ||
| Q3 24 | $-0.18 | $-0.07 | ||
| Q2 24 | $-0.17 | — | ||
| Q1 24 | $-0.20 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $96.2M | $2.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $107.5M | $6.6M |
| 总资产 | $185.0M | $16.0M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
LXRX
ROLR
| Q4 25 | $96.2M | — | ||
| Q3 25 | $116.0M | $2.7M | ||
| Q2 25 | $139.0M | $2.7M | ||
| Q1 25 | $194.8M | $3.5M | ||
| Q4 24 | $238.0M | — | ||
| Q3 24 | $258.4M | $1.3M | ||
| Q2 24 | $310.0M | — | ||
| Q1 24 | $355.6M | — |
股东权益
LXRX
ROLR
| Q4 25 | $107.5M | — | ||
| Q3 25 | $120.2M | $6.6M | ||
| Q2 25 | $129.4M | $2.6M | ||
| Q1 25 | $123.0M | $2.8M | ||
| Q4 24 | $145.9M | — | ||
| Q3 24 | $178.5M | $-779.0K | ||
| Q2 24 | $240.0M | — | ||
| Q1 24 | $288.9M | — |
总资产
LXRX
ROLR
| Q4 25 | $185.0M | — | ||
| Q3 25 | $205.9M | $16.0M | ||
| Q2 25 | $225.6M | $12.3M | ||
| Q1 25 | $297.7M | $12.8M | ||
| Q4 24 | $298.4M | — | ||
| Q3 24 | $321.1M | $12.9M | ||
| Q2 24 | $373.4M | — | ||
| Q1 24 | $417.2M | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-17.2M | $-78.0K |
| 自由现金流经营现金流 - 资本支出 | — | $-90.0K |
| 自由现金流率自由现金流/营收 | — | -1.4% |
| 资本支出强度资本支出/营收 | — | 0.2% |
| 现金转化率经营现金流/净利润 | — | -0.02× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势,按日历期对齐
经营现金流
LXRX
ROLR
| Q4 25 | $-17.2M | — | ||
| Q3 25 | $-23.8M | $-78.0K | ||
| Q2 25 | $17.0M | $-840.0K | ||
| Q1 25 | $-43.8M | $-3.6M | ||
| Q4 24 | $-178.8M | — | ||
| Q3 24 | $-53.6M | — | ||
| Q2 24 | $-48.5M | — | ||
| Q1 24 | $-55.1M | — |
自由现金流
LXRX
ROLR
| Q4 25 | — | — | ||
| Q3 25 | — | $-90.0K | ||
| Q2 25 | — | $-845.0K | ||
| Q1 25 | — | $-3.6M | ||
| Q4 24 | $-179.8M | — | ||
| Q3 24 | $-53.9M | — | ||
| Q2 24 | $-48.8M | — | ||
| Q1 24 | — | — |
自由现金流率
LXRX
ROLR
| Q4 25 | — | — | ||
| Q3 25 | — | -1.4% | ||
| Q2 25 | — | -12.2% | ||
| Q1 25 | — | -53.5% | ||
| Q4 24 | -11600.7% | — | ||
| Q3 24 | -3097.4% | — | ||
| Q2 24 | -3017.3% | — | ||
| Q1 24 | — | — |
资本支出强度
LXRX
ROLR
| Q4 25 | — | — | ||
| Q3 25 | 0.0% | 0.2% | ||
| Q2 25 | — | 0.1% | ||
| Q1 25 | — | 0.2% | ||
| Q4 24 | 66.5% | — | ||
| Q3 24 | 17.6% | — | ||
| Q2 24 | 15.5% | — | ||
| Q1 24 | 0.0% | — |
现金转化率
LXRX
ROLR
| Q4 25 | — | — | ||
| Q3 25 | — | -0.02× | ||
| Q2 25 | 5.23× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LXRX
暂无分部数据
ROLR
| Net Gaming Revenue | $4.9M | 77% |
| Net Revenue Noncore Services | $1.4M | 23% |